Zoetis Raises Annual Forecast Amid Strong Demand for Pet Products
Zoetis Inc., a leader in animal healthcare, has recently raised its annual revenue and profit forecasts for 2025. This boost is largely driven by a surge in demand for pet medicines and vaccines. In the second quarter of this year, Zoetis’s companion animal segment reported an impressive 8% revenue increase. Products such as Simparica Trio and Librela have been key contributors to this growth, reflecting broader trends in the pet healthcare market.
Continue Reading on Meyka
This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.
Read Full Article →
